Disclosure information not submitted.
Real-world Comparison Of Standard Vs. Reduced-dose Apixaban In Stroke Prevention And Bleeding Risk In Atrial Fibrillation Patients With Chronic Kidney Disease: A Retrospective Analysis Of Trinetx Data
Saturday, March 8, 202511:16 AM – 11:24 AM ET
